This course reviews the treatment guidelines for children with the most common benign and malignant tumors of childhood, with a focus on radiotherapy. Indications for radiotherapy are discussed, in addition to radiotherapy planning guidelines. Clinical outcomes including disease control and toxicity are examined.
The meeting is designed to meet the interests of practicing radiation oncologists, radiation oncology residents, medical and clinical physicists, nurses and all other health professionals involved in the field of radiation oncology.
Upon completion of this activity, participants should be able to do the following:
- Formulate treatment recommendations for common pediatric tumors.
- Develop radiation treatment plans using appropriate dose, volume, and planning parameters.
- Recognize the potential acute and late toxicity associated with radiotherapy in the pediatric population.
Julie Bradley, MD is employed by the UF Health Proton Therapy Institute and has no financial relationships with a commercial interest.
All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.00 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.